A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...

Regular use of strong opioids may significantly increase risk for all-cause and vascular dementia plus reduced brain volume and cognitive performance.

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. | Drug ...

What makes this tool innovative is its ability to detect subtle brain activity patterns often invisible to the human eye and ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...

Vascular dementia is the second most common type of dementia after Alzheimer’s disease. It happens when blood flow to the brain is reduced or blocked, usually due to strokes or damage to small blood ...

Learn how to manage dementia and heart disease simultaneously. Discover medication tips, lifestyle changes, and care strategies for dual conditions.

Sparse Data on Systemic Treatments and Psoriasis. Several international reports have linked psoriasis with dementia, including a 2019 study that found an elevated risk associated with the skin ...

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF), a leading Phase III autologous stem cell therapy company and Mr. Croom Lawrence ...